abstract |
The present invention is related to 4-amino-6-(2,6-dichlorophenyl)-2- (phenylamino)-pyrido[2,3-d]pyrimidin-7(8H)-one derivatives, to the preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in the treatment and/or prevention of a non-Hodgkin's lymphoma. |